Register entry
- Registered sites
- 0
- Active NDC listings
- 11
- Labeller names
- 2
- Live patents
- 30
- Countries
- 0
Catalogue
Drug listings by form and route
1111 active NDC listings: 11 human prescription drug. By marketing category: UNAPPROVED DRUG OTHER 6, NDA 5.
| Dosage form | NDCs |
|---|---|
| kit | 4 |
| tablet | 3 |
| capsule, liquid filled | 2 |
| capsule, gelatin coated | 1 |
| gel | 1 |
| Route | NDCs |
|---|---|
| oral | 6 |
| topical | 1 |
| Labeller name on the listing | NDCs |
|---|---|
| exeltis usa, inc. | 10 |
| exeltis usa, inc | 1 |
Exclusivity
Patents and exclusivities
30| Patent | Product | Covers | Expiry |
|---|---|---|---|
| 10179140 | DROSPIRENONE, SLYNDdrospirenone | use | Jun 2031 |
| 10603281 | DROSPIRENONE, SLYNDdrospirenone | use | Jun 2031 |
| 10849857 | DROSPIRENONE, SLYNDdrospirenone | product | Jun 2031 |
| 10987364 | DROSPIRENONE, SLYNDdrospirenone | product | Jun 2031 |
| 11123299 | DROSPIRENONE, SLYNDdrospirenone | product | Jun 2031 |
| 11291632 | DROSPIRENONE, SLYNDdrospirenone | product | Jun 2031 |
| 11291633 | DROSPIRENONE, SLYNDdrospirenone | product | Jun 2031 |
| 11351122 | DROSPIRENONE, SLYNDdrospirenone | product | Jun 2031 |
| 11413249 | DROSPIRENONE, SLYNDdrospirenone | use | Jun 2031 |
| 11439598 | DROSPIRENONEdrospirenone | product | Jun 2031 |
| 11478487 | DROSPIRENONE, SLYNDdrospirenone | product | Jun 2031 |
| 11504334 | DROSPIRENONE, SLYNDdrospirenone | product | Jun 2031 |
| 11951213 | DROSPIRENONE, SLYNDdrospirenone | use | Jun 2031 |
| 12090231 | DROSPIRENONE, SLYNDdrospirenone | use | Jun 2031 |
| 12280151 | SLYNDdrospirenone | product | Jun 2031 |
| 9603860 | DROSPIRENONE, SLYNDdrospirenone | use | Jun 2031 |
Catalogue
Marketed products
11| Brand | Generic name | Form / route | NDC |
|---|---|---|---|
| Benznidazole | benznidazole | tablet, oral | 0642-7463NDA |
| Benznidazole | benznidazole | tablet, oral | 0642-7464NDA |
| Nuvessa | metronidazole | gel, topical | 0642-7466NDA |
| SLYND | Drospirenone | kit | 0642-7470NDA |
| Select-OB Plus DHA Prenatal Supplement Plus DHA | .BETA.-CAROTENE, VITAMIN A ACETATE, ASCORBIC ACID, CHOLECALCIFEROL, .ALPHA.-TOCOPHEROL ACETATE, DL-, Thiamine Mononitrate, Riboflavin, NIACINAMIDE, Pyridoxine Hydrochloride, Folic Acid, LEVOMEFOLATE CALCIUM, Cobalamin, Iron, MAGNESIUM OXIDE, ZINC OXIDE, and DOCONEXANT | kit | 0642-0075UNAPPROVED DRUG OTHER |
| Strovite One Caplets | Vitamin A, Calcium Pantothenate, Ascorbic Acid, Cholecalciferol, .Alpha.-Tocopherol Succinate, D-, Thiamine, Riboflavin, Niacinamide, Pyridoxine Hydrochloride, Folic Acid, Biotin, Cyanocobalamin, Selenium, Magnesium Oxide, Zinc Oxide, Cupric Sulfate, Manganese, Chromium, .Alpha.-Lipoic Acid, and Lutein | tablet, oral | 0642-0207UNAPPROVED DRUG OTHER |
| Tyblume | Levonorgestrel and Ethinyl Estradiol | kit | 0642-7471NDA |
| Vitafol Fe Plus | DOCONEXENT, NIACINAMIDE, .ALPHA.-TOCOPHEROL ACETATE, DL-, CHOLECALCIFEROL, BETA CAROTENE, ASCORBIC ACID, THIAMINE MONONITRATE, Riboflavin, Pyridoxine Hydrochloride, CYANOCOBALAMIN, Iron, ZINC OXIDE, CUPRIC OXIDE, POTASSIUM IODIDE, MAGNESIUM OXIDE, Folic Acid, and LEVOMEFOLATE CALCIUM | capsule, liquid filled, oral | 0642-7473UNAPPROVED DRUG OTHER |
| Vitafol One | Prenatal Supplement with DHA | capsule, gelatin coated, oral | 0642-0070UNAPPROVED DRUG OTHER |
| Vitafol Ultra | Doconexent, Niacinamide, .Alpha.-Tocopherol Acetate, DL-, Cholecalciferol, .Beta.-Carotene, Ascorbic Acid, Thiamine Mononitrate, Riboflavin, Pyridoxine Hydrochloride, Cyanocobalamin, Iron, Zinc Oxide, Cupric Oxide, Potassium Iodide, Magnesium Oxide, Folic Acid, and Levomefolate Calcium | capsule, liquid filled, oral | 0642-0093UNAPPROVED DRUG OTHER |
| Vitafol-OB Plus DHA Prenatal Supplement Plus DHA | Vitamin A, Ascorbic Acid, Vitamin D, .Alpha.-Tocopherol, Thiamine Mononitrate, Riboflavin, Niacin, Pyridoxine Hydrochloride, Folic Acid, Cyanocobalamin, Calcium, Iron, Magnesium, Zinc, Copper, and Doconexent | kit | 0642-0076UNAPPROVED DRUG OTHER |
Enquiry
Common questions
- Is Exeltis USA, Inc. FDA approved?
- Exeltis USA, Inc. holds no registered establishment of its own; 11 drug products are listed under its name in the National Drug Code Directory, made at sites registered to other firms.
- What drugs does Exeltis USA, Inc. make?
- 11 products are listed under Exeltis USA, Inc. in the openFDA NDC Directory, most often as kit; tablet; capsule, liquid filled. The full breakdown by dosage form and route is above. A listing count is not a sales figure.
Compiled from FDA establishment registrations, the openFDA NDC Directory, the Orange Book and the FDA drug shortage database. Not claimed by the company. Sources and methodology.